Who Paid My Doc
Dan Streja
Endocrinology, Diabetes & Metabolism West Hills, CA Medical Doctor
NPI 1467464404 CMS profile 65906
7345 Medical Center Dr, Suite 600, West Hills, CA 91307
General payments
$9,973
Research payments
$8,918
Ownership & investment interest
$0
Research they led as principal investigator
$2,989,818
Through program year 2023, Dan Streja of West Hills, CA is reported in the CMS Open Payments database as having received $9,973 across 223 general payments and $8,918 in research payments paid to them. Separately, studies naming them as principal investigator received $2,989,818 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 84th percentile of Endocrinology, Diabetes & Metabolism profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $198 | 8 | |
| 2022 | General | $1,042 | 59 | |
| 2022 | Research | $4,850 | 1 | |
| 2021 | General | $653 | 35 | |
| 2021 | Research | $4,068 | 1 | |
| 2020 | General | $873 | 40 | |
| 2019 | General | $7,208 | 81 |
Beside peers
- Dan Streja
- Endocrinology, Diabetes & Metabolism median
- Middle half of Endocrinology, Diabetes & Metabolism
- National median
In program year 2025, general payments to Dan Streja were reported at $0. Among 5,868 Endocrinology, Diabetes & Metabolism profiles paid that year, the median was $507 and the middle half received between $135 and $1,838.
Show as a table
| Year | Dan Streja | Endocrinology, Diabetes & Metabolism median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $7,208 | $494 | $123–$2,253 | $163 |
| 2020 | $873 | $335 | $85–$1,841 | $114 |
| 2021 | $653 | $398 | $88–$1,981 | $132 |
| 2022 | $1,042 | $364 | $88–$1,568 | $149 |
| 2023 | $198 | $420 | $113–$1,614 | $160 |
| 2024 | $0 | $440 | $121–$1,646 | $164 |
| 2025 | $0 | $507 | $135–$1,838 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
225 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Endocrinology, Diabetes & Metabolism in California
Juan Frias
Endocrinology, Diabetes & Metabolism · San Diego, CA
Joselito Cabaccan
Endocrinology, Diabetes & Metabolism · San Jose, CA
Daniel Nadeau
Endocrinology, Diabetes & Metabolism · Newport Beach, CA
Yehuda Handelsman
Endocrinology, Diabetes & Metabolism · Tarzana, CA
Helen Baron
Endocrinology, Diabetes & Metabolism · Rancho Mirage, CA
Ken Fujioka
Endocrinology, Diabetes & Metabolism · San Diego, CA
Related records
Endocrinology, Diabetes & Metabolism in California
Practitioners in the same specialty and state, ranked by reported value.
All Endocrinology, Diabetes & Metabolism
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.